48,584
edits
Difference between revisions of "Programmed death-ligand 1"
Jump to navigation
Jump to search
Programmed death-ligand 1 (view source)
Revision as of 03:57, 9 November 2018
, 03:57, 9 November 2018→Drugs - Immune checkpoint inhibitors
(+IHC) |
|||
| Line 45: | Line 45: | ||
**Durvalumab (''Imfinzi'', AstraZeneca). | **Durvalumab (''Imfinzi'', AstraZeneca). | ||
**Avelumab (''Bavencio'', Merck/Pfizer). | **Avelumab (''Bavencio'', Merck/Pfizer). | ||
===Anti-PD-L1 drugs - use=== | ===Anti-PD-L1 drugs - use=== | ||